Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA208257 | The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer | 1 | 2022 |
| R01CA218545 | Novel approach to attenuate small cell lung cancer growth and metastasis | 1 | 2022 |
| R01CA221158 | Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancer | 1 | 2022 |
| R01CA223483 | Investigating the metastatic drive in pancreas cancer | 1 | 2022 |
| R01CA224493 | Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs | 1 | 2022 |
| R01CA226983 | Directing the metabolic fate of CAR T cells | 1 | 2022 |
| R01CA227737 | BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia | 1 | 2022 |
| R01CA231141 | Genetics of Graft-versus-Host Disease | 1 | 2022 |
| R01DE027749 | Head & Neck Cancer Neoantigen Characterization & Therapeutic Targeting | 1 | 2022 |
| R01DK042191 | Cytokines and Inflammatory Bowel Disease | 1 | 2022 |
| R01DK068306 | Novel genetics, pathobiology and therapy of nephronophthisis-related ciliopathies | 1 | 2022 |
| R01DK117913 | The Role of LRG1 in Diabetic Kidney Disease | 1 | 2022 |
| R01DK126702 | Unconventional myosins and the regulation of gut barrier integrity and restitution during inflammation | 1 | 2022 |
| R01EB027660 | An Engineered Tissue Model of Aged Mammary Microenvironment | 1 | 2022 |
| R01ES028721 | Developmental windows for arsenic-associated diabetes | 1 | 2022 |
| R01ES029212 | Placental Functional Networks Linking Developmental Pesticide Exposure and Offspring Neurodevelopment | 1 | 2022 |
| R01ES029280 | Environmental Exposures, AHR Activation, and Placental Origins of Development | 1 | 2022 |
| R01ES031534 | FTO and RNA methylation in arsenic tumorigenicity | 1 | 2022 |
| R01EY027011 | Molecular Mechanisms of Glaucoma | 1 | 2022 |
| R01EY027749 | A Diabetic Retinopathy-Associated Vascular Permeability Factor | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=34